Bardiès M - Search Results

1

Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies.

Gestin JF, Loussouarn A, Bardiès M, Gautherot E, Gruaz-Guyon A, Saï-Maurel C, Barbet J, Curtet C, Chatal JF, Faivre-Chauvet A. Gestin JF, et al. Among authors: bardies m. J Nucl Med. 2001 Jan;42(1):146-53. J Nucl Med. 2001. PMID: 11197965 Free article.

2

Comparison of technetium-99mC and phytate aerosol in ventilation studies.

Peltier P, Bardies M, Chetanneau A, Chatal JF. Peltier P, et al. Among authors: bardies m. Eur J Nucl Med. 1992;19(5):349-54. doi: 10.1007/BF00177057. Eur J Nucl Med. 1992. PMID: 1319333

3

Use of multi-cell spheroids of ovarian carcinoma as an intraperitoneal radio-immunotherapy model: uptake, retention kinetics and dosimetric evaluation.

Bardiès M, Thedrez P, Gestin JF, Marcille BM, Guerreau D, Faivre-Chauvet A, Mahé M, Sai-Maurel C, Chatal JF. Bardiès M, et al. Int J Cancer. 1992 Apr 1;50(6):984-91. doi: 10.1002/ijc.2910500627. Int J Cancer. 1992. PMID: 1555897

4

MIBG scintigraphy of a patient with pheochromocytoma on labetalol therapy.

Morais J, Le Marec H, Peltier P, Chetanneau A, Kremer M, Bardies M, Chatal JF. Morais J, et al. Among authors: bardies m. Clin Nucl Med. 1992 Apr;17(4):308-11. doi: 10.1097/00003072-199204000-00011. Clin Nucl Med. 1992. PMID: 1572122

5

Does immunoscintigraphy serve clinical needs effectively? Is there a future for radioimmunotherapy?

Chatal JF, Peltier P, Bardiès M, Chétanneau A, Thedrez P, Faivre-Chauvet A, Gestin JF. Chatal JF, et al. Among authors: bardies m. Eur J Nucl Med. 1992;19(3):205-13. doi: 10.1007/BF00173283. Eur J Nucl Med. 1992. PMID: 1572386 Review.

6

Bifunctional antibodies for radioimmunotherapy.

Chatal JF, Faivre-Chauvet A, Bardies M, Peltier P, Gautherot E, Barbet J. Chatal JF, et al. Among authors: bardies m. Hybridoma. 1995 Apr;14(2):125-8. doi: 10.1089/hyb.1995.14.125. Hybridoma. 1995. PMID: 7590767 Review.

7

Pharmacokinetics and biodistribution of samarium-153-labelled OC125 antibody coupled to CITCDTPA in a xenograft model of ovarian cancer.

Kraeber-Bodéré F, Mishra A, Thédrez P, Faivre-Chauvet A, Bardiès M, Imai S, Le Boterff J, Chatal JF. Kraeber-Bodéré F, et al. Among authors: bardies m. Eur J Nucl Med. 1996 May;23(5):560-7. doi: 10.1007/BF00833392. Eur J Nucl Med. 1996. PMID: 8698062

8

Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody.

Faivre-Chauvet A, Mease RC, Chetanneau A, Bardiès M, Sai-Maurel C, Meinken GE, Srivastava SC, Chatal JF, Gestin JF. Faivre-Chauvet A, et al. Among authors: bardies m. Nucl Med Commun. 1996 Sep;17(9):781-9. doi: 10.1097/00006231-199609000-00008. Nucl Med Commun. 1996. PMID: 8895905

9

Cell death induced by a 131I-labeled monoclonal antibody in ovarian cancer multicell spheroids.

Filippovich IV, Sorokina N, Robillard N, Faivre-Chauvet A, Bardies M, Chatal JF. Filippovich IV, et al. Among authors: bardies m. Nucl Med Biol. 1996 Jul;23(5):623-6. doi: 10.1016/0969-8051(96)00059-5. Nucl Med Biol. 1996. PMID: 8905827

10

Bispecific antibody and iodine-131-labeled bivalent hapten dosimetry in patients with medullary thyroid or small-cell lung cancer.

Bardiès M, Bardet S, Faivre-Chauvet A, Peltier P, Douillard JY, Mahé M, Fiche M, Lisbona A, Giacalone F, Meyer P, Gautherot E, Rouvier E, Barbet J, Chatal JF. Bardiès M, et al. J Nucl Med. 1996 Nov;37(11):1853-9. J Nucl Med. 1996. PMID: 8917192 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters